Erosive Esophagitis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: Nexium 20mg; Drug: Nexium 10mg Sponsors: AstraZeneca; IQVIA RDS Inc.; Calyx; Labcorp Central Laboratory Services; Medidata Solutions; Thermo Fisher Scientific; CISCRP (Center for Information and Study on Clinical Research Participation); Quipment Inc.; Little Journey Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials
